Amgen's Prolia Gains First Regulatory Win: Market Approval in Europe

 
• By The Pink Sheet Daily

Amgen and GlaxoSmithKline will assume marketing responsibilities in Europe for osteoporosis, and Amgen will market it for oncology.

More from Europe

More from Geography